Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07114120

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
214 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if Bailing Capsules in combination Guben Kechuan Granules works to treat stable bronchiectasis in adults.It will also learn about the safety of Bailing Capsules in combination Guben Kechuan Granules The main questions it aims to answer are: Does Bailing Capsules in combination Guben Kechuan Granules lower the number of acute exacerbation in patients with stable bronchiectasis? The safety of the combination of Bailing Capsules and Guben Kechuan Granules ? Researchers will compare the combination of Bailing Capsules and Guben Kechuan Granules to standard Western medical treatment to see if them works to treat stable bronchiectasis. Participants will: Take Bailing Capsules orally (four capsules each time, three times a day) and Guben Kechuan Granules ( three times a day, 1 bag each time )on the basis of standard Western medical treatment or only standard Western medical treatment for 24 weeks Visit the clinic for checkups and tests on 4, 12, 24, 48 weeks Keep a diary of their symptoms

Conditions

Interventions

TypeNameDescription
DRUGBailing Capsules in combination Guben Kechuan GranulesBailing Capsules (four capsules each time, three times a day) in combination Guben Kechuan Granules (1 bag each time,three times a day,)

Timeline

Start date
2025-07-14
Primary completion
2027-10-30
Completion
2027-12-30
First posted
2025-08-11
Last updated
2025-08-11

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07114120. Inclusion in this directory is not an endorsement.